Schimmer AD - Search Results

1

Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligands.

Wood TE, Dalili S, Simpson CD, Sukhai MA, Hurren R, Anyiwe K, Mao X, Suarez Saiz F, Gronda M, Eberhard Y, MacLean N, Ketela T, Reed JC, Moffat J, Minden MD, Batey RA, Schimmer AD. Wood TE, et al. Among authors: schimmer ad. Mol Cancer Ther. 2010 Jan;9(1):246-56. doi: 10.1158/1535-7163.MCT-09-0495. Epub 2010 Jan 6. Mol Cancer Ther. 2010. PMID: 20053768

2

Osteoporosis after blood and marrow transplantation: clinical aspects.

Schimmer AD, Minden MD, Keating A. Schimmer AD, et al. Biol Blood Marrow Transplant. 2000;6(2A):175-81. doi: 10.1016/s1083-8791(00)70040-1. Biol Blood Marrow Transplant. 2000. PMID: 10816025 Free article. Review. No abstract available.

3

The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2.

Schimmer AD, Hedley DW, Chow S, Pham NA, Chakrabartty A, Bouchard D, Mak TW, Trus MR, Minden MD. Schimmer AD, et al. Cell Death Differ. 2001 Jul;8(7):725-33. doi: 10.1038/sj.cdd.4400870. Cell Death Differ. 2001. PMID: 11464217

4

BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential.

Schimmer AD, Hedley DW, Pham NA, Chow S, Minden MD. Schimmer AD, et al. Leuk Lymphoma. 2001 Jul;42(3):429-43. doi: 10.3109/10428190109064600. Leuk Lymphoma. 2001. PMID: 11699408

5

Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view.

Schimmer AD, Hedley DW, Penn LZ, Minden MD. Schimmer AD, et al. Blood. 2001 Dec 15;98(13):3541-53. doi: 10.1182/blood.v98.13.3541. Blood. 2001. PMID: 11739155 Free article. Review. No abstract available.

6

Dysregulation of apoptosis genes in hematopoietic malignancies.

Kitada S, Pedersen IM, Schimmer AD, Reed JC. Kitada S, et al. Among authors: schimmer ad. Oncogene. 2002 May 13;21(21):3459-74. doi: 10.1038/sj.onc.1205327. Oncogene. 2002. PMID: 12032782 Review.

7

Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy.

Schimmer AD, Pedersen IM, Kitada S, Eksioglu-Demiralp E, Minden MD, Pinto R, Mah K, Andreeff M, Kim Y, Suh WS, Reed JC. Schimmer AD, et al. Cancer Res. 2003 Mar 15;63(6):1242-8. Cancer Res. 2003. PMID: 12649183

8

Bcl-2 and apoptosis in chronic lymphocytic leukemia.

Schimmer AD, Munk-Pedersen I, Minden MD, Reed JC. Schimmer AD, et al. Curr Treat Options Oncol. 2003 Jun;4(3):211-8. doi: 10.1007/s11864-003-0022-y. Curr Treat Options Oncol. 2003. PMID: 12718798 Review.

9

Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL.

Suh WS, Kim YS, Schimmer AD, Kitada S, Minden M, Andreeff M, Suh N, Sporn M, Reed JC. Suh WS, et al. Among authors: schimmer ad. Leukemia. 2003 Nov;17(11):2122-9. doi: 10.1038/sj.leu.2403112. Leukemia. 2003. PMID: 12931220

10

The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice.

Pham NA, Jacobberger JW, Schimmer AD, Cao P, Gronda M, Hedley DW. Pham NA, et al. Among authors: schimmer ad. Mol Cancer Ther. 2004 Oct;3(10):1239-48. Mol Cancer Ther. 2004. PMID: 15486191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters